Press releases

AIRE, a key factor in the unequal impact of autoimmune diseases on men and women

Press release | 29 Apr 2016 - 15h23 | By INSERM PRESS OFFICE
Immunology, inflammation, infectiology and microbiology

Nadine Dragin, a researcher from an Inserm/UPMC/CNRS/AIM team codirected by Sonia Berrih-Aknin and Rozen le Panse at the Institute of Myology, based at Pitié-Salpêtrière Hospital, AP-HP, has demonstrated the central role of AIRE, a key factor in immune tolerance, in the unequal impact of autoimmune diseases on men and women. This work, published in The Journal of Clinical Investigation on 1 April 2016, was funded by AFM-Téléthon.

Projet FIGHT-MG

(c) Inserm / Delapierre Patrick

Autoimmune diseases result from a malfunction of the immune system that attacks normal constituents of the body known as “autoantigens.” They affect 5–8% of the population, and affect women more than men. They thus represent the fifth leading cause of death in women of childbearing age.

To explain this inequality, the researchers from the Institute of Myology focused on thymic tolerance mechanisms, i.e. this state of immune non-response to an antigen. The research teams observed that the Auto-Immune REgulator (AIRE), a key factor in immune tolerance, is less strongly expressed in women than in men.

AIRE controls the expression of tissue-specific antigens on the epithelial cells of the thymus (a lymphoid organ that produces components of the immune system in humans). On contact with epithelial cells expressing these specific antigens, potentially pathogenic cells receive signals that lead to their destruction. A decrease in AIRE expression leads to reduced expression of these specific antigens, and hence to less efficient elimination of the cells. This phenomenon is observed after puberty, when the thymus in both women and female mice expresses less AIRE than that in males, leading to poorer immune tolerance, and hence to greater susceptibility to autoimmune disease. The researchers also showed that oestrogen was the hormone responsible for this effect, since oestrogen treatment of thymic epithelial cells from humans and mice resulted in a decrease in AIRE expression in these cells.

Taken together, these results therefore indicate that, in females, oestrogen induces changes in the expression of the AIRE gene, thereby increasing the sensitivity of women to autoimmune diseases. AIRE expression levels may therefore indicate a predisposition to an autoimmune disease, and make the oestrogen level a potential therapeutic target.

TO CITE THIS POST :
Press release – Inserm press room AIRE, a key factor in the unequal impact of autoimmune diseases on men and women Link : http://presse.inserm.fr/en/aire-a-key-factor-in-the-unequal-impact-of-autoimmune-diseases/23767/
Medias
Researcher Contact
chercheur

Sonia Berrih-Aknin

sonia.berrih-aknin@upmc.fr
Nadine Dragin

nadine.dragin-mamavi@upmc.fr

Press Contact

AFM-Téléthon/Institut de Myologie

Karima Jaoudi +33 (0)1.69.47.11.71 kjaoudi@afm-telethon.fr
AP-HP

Anne-Cécile Bard/ Marine Leroy – +33 (0)1.40.27.37.22 – service.presse@aphp.fr
CNRS

Samira Techer – +33 (0)1.44.96.46.37 presse@cnrs.fr
Inserm

Priscille Rivière +33 (0)1.44.23.60.97 priscille.riviere@inserm.fr

UPMC

Claire de Thoisy-Mechin – +33 (0)1.44.27.23.34

claire.de_thoisy-mechin@upmc.fr

Sources

“Estrogen-mediated downregulation of AIRE influences sexual dimorphism in autoimmune diseases”

Nadine Dragin,1,2,3,4 Jacky Bismuth,1,2,3,4 Géraldine Cizeron-Clairac,5 Maria Grazia Biferi,1,2,3,4 Claire Berthault,6,7 Alain Serraf,8Rémi Nottin,8 David Klatzmann,9 Ana Cumano,6 Martine Barkats,1,2,3,4 Rozen Le Panse,1,2,3,4 and Sonia Berrih-Aknin1,2,3,4

1Sorbonne University, UPMC University of Paris 6, Paris, France.

2INSERM U974, Paris, France.

3CNRS FRE 3617, Paris, France.

4AIM, Institute of Myology, Paris, France.

5CNRS UMR 8162, Le Plessis–Robinson, France.

6INSERM U668, Unit for Lymphopoiesis, Immunology Department, Institut Pasteur, Paris, France. 7Paris Diderot University, Sorbonne Paris Cité, Cellule Pasteur, Paris, France.

8Marie Lannelongue Hospital, Le Plessis–Robinson, France.

9Paris Public Hospitals (AP-HP), Pitié-Salpêtrière Hospital, Biotherapy, Paris, France.

https://www.jci.org/articles/view/81894

fermer
fermer
RSS Youtube